[Federal Register Volume 62, Number 150 (Tuesday, August 5, 1997)]
[Notices]
[Pages 42137-42138]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20555]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the Drug Testing Advisory Board of the SAMHSA Center for Substance 
Abuse Prevention in September 1997.
    The two-day scientific meeting will be to continue discussing 
alternative specimens and technologies of drug testing (i.e., hair, 
saliva, sweat, and non-instrument based-on-site tests) as they apply to 
workplace drug testing programs. The entire meeting is open to the 
public; however, attendance by the public will be limited to space 
available. Therefore, it would be helpful if those planning to attend 
would pre-register by following Registration instructions below. There 
will be a limited time for public comment during the meeting. If anyone 
needs special accommodations for persons with disabilities please 
notify the Contact listed below. Any individual desiring to make a 
formal comment should notify the Contact person listed below before 
August 29.
    The purpose of the meeting is: (1) To review the proposed 
principles and criteria associated with a forensic workplace drug 
testing program that were presented at the April 28-30, 1997, DTAB 
meeting and determine if those are the appropriate standards that any 
drug testing program needs to satisfy; (2) to review the information 
and scientific studies presented or submitted by the representatives of 
the alternative specimens and technology industries during and/or after 
the April 28-30 DTAB meeting, to determine their strengths and 
weaknesses, what criteria they satisfy, and what areas may need 
improvement; and (3) to make recommendations to assist these 
alternative specimens and technologies to satisfy the criteria.
    An agenda for this meeting and a roster of board members may be 
obtained from: Ms. Giselle Hersh, Division of Workplace Programs, Room 
13A-54, 5600 Fishers Lane, Rockville, MD 20857, Telephone (301) 443-
6014.
    Substantive program information may be obtained from the contact 
whose name and telephone number is listed below.

    Committee Name: Drug Testing Advisory Board.
    Meeting Date: September 9-10, 1997.
    Place: Sheraton National Hotel, Columbia Pike & Washington Blvd, 
Arlington, Virginia 22204, Phone: (800) 468-9090.
    Open: September 9, 1997, 8:30 a.m.-5:00 p.m., September 10, 
1997, 8:30 a.m.-4:00 p.m.
    Registration: Pre-register by calling: (301) 443-6014 or by FAX: 
(301) 443-3031 for individuals planning to attend: full name, 
organization and telephone number or sign in upon arrival; there is 
no registration fee.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, Telephone: 
(301) 443-6014 and FAX: (301) 443-3031.


[[Page 42138]]


    Dated: July 30, 1997.
Jeri Lipov,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 97-20555 Filed 8-4-97; 8:45 am]
BILLING CODE 4162-20-M